Pharmacy Times

MAY 8, 2025

The agent demonstrated promising tolerability and manageable safety.

Safety 32

Safety Management FDA 32

European Pharmaceutical Review

MAY 15, 2025

This treatment is designed to address the underlying orexin deficiency in the chronic neurological condition, according to Takeda.

Medicine 52

Medicine Leads Pharmaceutical 52

European Pharmaceutical Review

MAY 27, 2025

The Irish medicines regulatory agency, requested this action under Article 31 of Directive 2001/83/EC. Start of referral The CHMP has started a review of available information on the benefits and risks of ipidacrine-containing medications, largely indicated to treat disorders affecting the nervous system.

Medicine 59

Medicine Medical Pharmaceutical Marketing 59

Pharmaceutical Technology

NOVEMBER 18, 2024

Intellia presented data from its Phase I study of NTLA-2001 at the 2024 American Heart Association scientific meeting in Chicago.

52

52

Pharmacy Times

MAY 8, 2024

Ongoing and active shortages are currently at the highest number since January 2001.

Prescription 52

Prescription 52

pharmaphorum

DECEMBER 1, 2022

Led by the MPE CEE Workgroup on Access, the report – Addressing access barriers to myeloma clinical trials in Central and Eastern Europe – evaluated the number of clinical trials held in CEE countries between 1 January 2001 and 28 September 2020. Approximately 50,000 people in Europe are diagnosed with myeloma each year.

Patients 72

Patients Physicians Leads 72

Pharmaceutical Technology

JULY 10, 2023

The US FDA has granted orphan drug designation (ODD) for Ichnos Sciences’ ISB 2001 to treat patients with multiple myeloma.

FDA 52

FDA Patients 52

European Pharmaceutical Review

JUNE 24, 2022

Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. One of the key priorities of the EU’s strategy is to encourage innovation to solve unmet medical needs. Brussels; 2020.

Pharmaceutical 105

Pharmaceutical Medicine Marketing Competition 105

European Pharmaceutical Review

APRIL 13, 2023

For example, the relaxed attitude towards cannabis in the Netherlands is well-known and Portugal has decriminalised the possession and consumption of all illicit substances since 2001.

Medicine 131

Medicine Food and Drug Administration Doctors Medical 131

European Pharmaceutical Review

JANUARY 25, 2024

Proposal for a Directive of the European Parliament and of the Council on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC.” References European Commission, (26 April 2023). Article 63 EMA (29 January 2020). Article 63 Euractiv (26 September 2023).

Healthcare 98

Healthcare Healthcare Electronics Safety 98

Pharmaceutical Technology

JULY 18, 2022

The latest contract comes after previous agreements between the parties for seasonal influenza and pandemic vaccines dating back to 2001. The company intends to supply both vaccines from its 230,000ft² Sainte-Foy facility in Quebec. .

Government 64

Government Pharmaceutical 64

European Pharmaceutical Review

JULY 4, 2024

11 The THR pathway was created with the purpose of establishing a simplified registration procedure for all traditional herbal medicines that do not fulfil the requirements for the MA (strict) pathway under Directive 2001/83/EC. 10,12 The THR scheme is also limited to products used for oral or external use and/or inhalation. 2012/1916).

Marketing 103

Marketing Food and Drug Administration Medicine Prescription 103

Pharma Leaders

MAY 12, 2023

Founded in 2001 and headquartered in Guelph, Ontario, Canada, Nutrasource is a global contract research organisation (CRO) in the pharmaceutical and nutraceutical businesses. The company will initially buy a 60% interest in Nutrasource while having the right to pick the remaining 40% holding in 2026.

Pharmaceutical 52

Pharmaceutical Management Marketing 52

European Pharmaceutical Review

FEBRUARY 22, 2023

Following post-doctoral studies on proteomics at Purdue University, under supervision of Professor Fred E Regnier, Ahmad joined the SMPA laboratory in 2001. Molecular recognition and supramolecular chemistry in the gas phase, Mass Spectrom Rev , 2001, 20, 253-309. Schalley CA. Lee JU, Lee SS, Lee S, et al.,

Electronics 98

Electronics Food Pharmaceutical Doctors 98

Pharmaceutical Technology

JUNE 29, 2022

During 2001–10, the number of granted designations almost tripled, with 1,527 drugs receiving their first orphan drug designation. Based on Pharmaceutical Technology’s analysis, between 1983 and 2000, only 568 drugs received their first orphan drug designation for a specific therapeutic indication.

Food and Drug Administration 98

Food and Drug Administration Marketing FDA Pharmaceutical 98

European Pharmaceutical Review

SEPTEMBER 14, 2023

In 2001 and 2007, through 2009, the economy was hit hard. As a result of the economic uncertainty, 75 percent of life sciences company executives have experienced negative impacts on their business in the current macroeconomic climate. 1 We can only learn from the past and try not to repeat history.

Manufacturing 98

Manufacturing Engineering Management Pharmaceutical 98

Pharma Marketing Network

NOVEMBER 4, 2021

Since joining a Fortune 100 company in 2001 as a marketing manager for Roche, the world’s largest biotech company, global pioneer with 94K+ employees in 100 countries, and annual revenue of $53B, Jim has been promoted into multiple executive positions such as Global Marketing Manager, Global Group Manager, and Head of Global Digital Marketing.

Marketing 52

Marketing Media Management Leads 52

Clarivate

MAY 30, 2023

Since adopting IAS 38 Intangible Assets in 2001, the International Accounting Standards Board has made several revisions to reflect the growing importance of these assets. Recent reforms include new accounting standards for IP assets and new rules designed to increase transparency.

Management 59

Management Marketing 59

PM360

MAY 2, 2025

The initial approval of Mylotarg in 2001 marked a beginning; however, the journey since then has been marked with setbacks, leaving ADCs as a field often perceived as an unfulfilled promise. Ken Keller: Antibody-drug conjugates, while conceptually nearly a century old, have experienced resurgence and substantial progress in recent years.

Medicine 52

Medicine Competition Government Patients 52

PM360

OCTOBER 18, 2023

Since its inception in 2001, the company has successfully acquired and integrated 19 best-in-class healthcare agencies and consultancies across North America, Europe, and the Asia-Pacific region.

Healthcare 52

Healthcare Healthcare Consulting Marketing 52

pharmaphorum

OCTOBER 6, 2022

This is Barry Sharpless’ second Nobel Prize in Chemistry – the first was in 2001 for chiral catalysts. Johan Åqvist, chair of the Nobel Committee for Chemistry, said: “This year’s Prize in Chemistry deals with not overcomplicating matters, instead working with what is easy and simple.”.

Pharmaceutical research 52

Pharmaceutical research Pharmaceutical Medicine 52

European Pharmaceutical Review

DECEMBER 19, 2022

This is reflected in the legal basis for biosimilars under Article 6 of Regulation 726/2004 and Article 10(4) of Directive 2001/83 (as amended by Directive 2004/27). Directive 2001/83 (as amended). Information guide for healthcare professionals, EMA and EU Commission updated 2/10/2019. EMA Biosimilars Q&A.

Medicine 52

Medicine Biopharma Safety Food 52

European Pharmaceutical Review

DECEMBER 20, 2023

Draft Report on the proposal for a directive of the European Parliament and of the Council on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC. Internet] 2023. cited 2023Dec] Available from: [link] European Parliament.

Biopharma 98

Biopharma Pharmaceutical Medicine Manufacturing 98

Pharmaceutical Technology

FEBRUARY 24, 2023

Vouchers will grant one extra year of RDP, transferable to other drugs or sellable Stronger obligations for pharma companies to report shortages, and to offer a drug’s marketing authorisation to another company before withdrawing it from the market Requiring clinical trials in children where a drug is approved in adults for a different disease Introducing (..)

Pharma 64

Pharma Medicine Competition Food 64

Map My Customers

NOVEMBER 19, 2022

Although Microsoft first introduced Dynamics in 2001, it has only lately started to become a serious competitor with other well-known CRMs. Where Microsoft was once considered the dinosaur of the tech world, its current CEO, Satya Nadella, has brought Microsoft into the 21st century with innovative ideas and enhanced user-friendly design.

CRM 75

CRM Sales Prospecting B2B Sales 75

Clarivate

OCTOBER 31, 2023

What do the years 2001, 2007, 2014, and 2022 have in common? These years witnessed significant troughs in pharma financing, a drop in the capital markets, and an IPO window that remained firmly shut. In short, the biotech bubble had burst.

Pharma 52

Pharma Biopharma Marketing Healthcare 52

Pharmaceutical Technology

FEBRUARY 13, 2023

The first concept for a PROTAC was published in 2001, and recently these protein degraders have gained rapid momentum as a promising novel modality.

Competition 59

Competition Safety Patients Pharmaceutical 59

Legacy MEDSearch

OCTOBER 9, 2023

Also, only 3 procedure related CTCAE Grade 3 or higher adverse events through 30 days post-histotripsy were observed across all 44 subjects treated, representing a complication rate of 6.8% with each event being common to focal liver therapies and not specific to histotripsy.

FDA 52

FDA Food and Drug Administration Physicians Safety 52

Pharmaceutical Technology

MAY 3, 2023

from 2001 to 2022.” She says in those cases the FDA applies a multiple first-applicant approach to eligibility for 180-day exclusivity. However, that percentage of multiple first generics is not very high—approximately 10.6%

Food and Drug Administration 98

Food and Drug Administration FDA Medicine Competition 98

Pharmaceutical Technology

FEBRUARY 23, 2023

S54 – S61 (2001). Please check your email to download the Whitepaper. Grass and P. Sinko, “Effect of diverse datasets on the predictive capability of ADME models in drug discovery” Drug Discovery Today 6(12) (Suppl.)

Food and Drug Administration 98

Food and Drug Administration Pharmaceutical Food Side effects 98

European Pharmaceutical Review

JULY 20, 2023

Available from: [link] Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC (OJ L 33, 8.2.2003, p.30).

Safety 75

Safety Distribution Food Medical 75

PM360

NOVEMBER 12, 2024

Before joining Millennium in 2001, Barry served as executive vice president and chief business officer for Mediconsult.com, a healthcare consulting company. Greene was the general manager of Oncology at Millennium Pharmaceuticals, Inc., Food and Drug Administration approval and launch of VELCADE® (bortezomib) in mid-2003.

Food and Drug Administration 52

Food and Drug Administration Healthcare Provider Healthcare Healthcare 52

Pharmaceutical Technology

FEBRUARY 28, 2023

In the years between 2001-2010, a total of 1,527 designations were granted – almost triple the amount seen across the previous 17 years. Based on Pharmaceutical Technology’s analysis of GlobalData’s drugs database, a steep rise can be seen in the number of drugs receiving orphan drug designations in recent decades.

Medicine 52

Medicine Distribution Marketing Pharmaceutical 52

Pharmaceutical Technology

OCTOBER 5, 2008

“In 2001, Japan’s Taisho Pharmaceutical tried to merge with Tanabe, but it failed due to differences in corporate culture.’ “Japanese companies did very few M&As, they were too independent to do more,” says Kaoru K Sato, managing director at PricewaterhouseCoopers (PwC).

Government 40

Government Marketing Pharmaceutical Physicians 40

Pharmaceutical Technology

JULY 10, 2008

” When you consider only five big companies managed to earn 10% of their revenues from products launched after 2001 and those products still only generated income of $30.4bn, you are left with an industry where 90% of its revenue comes from medicines which are more than five years old.

Food and Drug Administration 40

Food and Drug Administration Medicine Pharmaceutical Government 40

CloserIQ

OCTOBER 10, 2018

Founded 2001. In a nod to the company’s playful spirit, employees who win monthly awards are given a Muppet statue. Buildium is hiring sales professionals across roles. OutSystems. 501-1000 employees. million in funding. See open roles.

Sales 76

Sales Management Marketing Education 76

Pharmaceutical Technology

JULY 11, 2025

July 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook AbbVie will gain exclusive rights to develop, manufacture and market ISB 2001 across several major regions. Credit: JHVEPhoto/Shutterstock. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate?

Media 52

Media Manufacturing Marketing Pharmaceutical 52